No Data
No Data
Wells Fargo Maintains UniQure NV(QURE.US) With Buy Rating, Maintains Target Price $35
Here's Why UniQure N.V. (QURE) Is Skyrocketing
Is UniQure N.V. (QURE) Among the Best Growth Stocks to Buy and Hold in 2025?
Can 2025 J.P. Morgan Healthcare Conference Spark Biotech M&A?
UniQure Shares Are Trading Lower After the Company Announced a Public Offering of 4.41 Million Shares.
UniQure Files Mixed Shelf; Shares Fall After Hours